FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Jan 10, 2020 $0.608 $0.679 $0.608 $0.620 31 989
Jan 09, 2020 $0.624 $0.670 $0.598 $0.605 13 643
Jan 08, 2020 $0.600 $0.699 $0.576 $0.650 9 047
Jan 07, 2020 $0.599 $0.640 $0.562 $0.598 10 834
Jan 06, 2020 $0.590 $0.590 $0.515 $0.570 14 973
Jan 03, 2020 $0.600 $0.615 $0.585 $0.585 29 506
Jan 02, 2020 $0.621 $0.630 $0.600 $0.615 8 817
Dec 31, 2019 $0.570 $0.640 $0.564 $0.602 28 863
Dec 30, 2019 $0.581 $0.630 $0.581 $0.590 79 495
Dec 27, 2019 $0.575 $0.635 $0.575 $0.585 145 790
Dec 26, 2019 $0.670 $0.670 $0.551 $0.570 46 788
Dec 24, 2019 $0.700 $0.704 $0.658 $0.659 4 985
Dec 23, 2019 $0.704 $0.710 $0.658 $0.700 18 711
Dec 20, 2019 $0.710 $0.720 $0.668 $0.704 16 969
Dec 19, 2019 $0.701 $0.735 $0.700 $0.720 12 986
Dec 18, 2019 $0.700 $0.714 $0.700 $0.714 22 739
Dec 17, 2019 $0.700 $0.774 $0.700 $0.701 4 484
Dec 16, 2019 $0.702 $0.735 $0.702 $0.705 887
Dec 13, 2019 $0.740 $0.800 $0.701 $0.705 10 185
Dec 12, 2019 $0.663 $0.718 $0.663 $0.710 14 727
Dec 11, 2019 $0.663 $0.740 $0.663 $0.740 21 286
Dec 10, 2019 $0.740 $0.740 $0.660 $0.700 22 794
Dec 09, 2019 $0.693 $0.740 $0.660 $0.740 4 518
Dec 06, 2019 $0.740 $0.740 $0.660 $0.660 4 839
Dec 05, 2019 $0.690 $0.740 $0.680 $0.740 26 333
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 1.95% $11.28
MLI Apr 19 11.07% $52.28
LPLA Apr 19 4.31% $262.59
DOOR Apr 18 0.90% $131.39
PFLT Apr 18 1.78% $11.25
LNG Apr 17 3.12% $156.81
FCN Apr 16 2.83% $207.62
ELV Apr 16 5.33% $506.97
AKR Apr 05 6.47% $16.53
ITCI Apr 05 5.64% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT